Treos Bio, an immuno-oncology company developing next-generation, off-the-shelf precision cancer vaccines coupled with companion diagnostics, today named Gábor Illés as its chief financial officer.    Mr. Illés has served as a non-executive investor director of Treos since the company’s inception, and has more than 20 years of corporate finance experience. He joins Treos from BXR Partners LLP, where he was a founding partner.    Mr. Illés, who will be based in Treos’ London headq...